Metric Finance
LearnFAQ
LearnFAQ

Learn / ONC

NASDAQ: ONC

BeOne Medicines Ltd. (ONC) stock, explained like you're 5

BeOne Medicines Ltd. trades on the Nasdaq under the ticker ONC. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 40.3 billion dollars.

Ticker
ONC
Exchange
Nasdaq
Sector
Healthcare
Industry
Pharmaceutical Preparations
Size
Large cap, about 40.3 billion dollars

Is BeOne Medicines Ltd. a small, medium or large cap company?

Yes. BeOne Medicines Ltd. is a large cap stock. Its market cap, which is the total value of all its shares, is about 40.3 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How BeOne Medicines Ltd. makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves ONC stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • When (ONC) Moves Investors should Listen (ONC:CA) (Stock Traders Daily)
  • All You Need to Know About BeOne Medicines Ltd. Sponsored ADR (ONC) Rating Upgrade to Strong Buy (Yahoo Finance)
  • JAZZ, ONC, ZYME Stocks In Focus After FDA Approves Gastroesophageal Cancer Therapy (Stocktwits)
  • BeOne Medicines (ONC) Stock Trades Above Fair Value Following Its 103% Run (Simply Wall Street)
  • BeOne Medicines (NASDAQ:ONC) Stock: Insider Xiaodong Wang Sells 31,027 Shares (MarketBeat)

Follow ONC in your daily brief

Each trading day at 5 PM ET we post what happened to BeOne Medicines Ltd. and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow ONC

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about BeOne Medicines Ltd. stock

What does BeOne Medicines Ltd. do?

BeOne Medicines Ltd. trades on the Nasdaq under the ticker ONC. It is a large cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 40.3 billion dollars.

What is the ticker symbol for BeOne Medicines Ltd.?

BeOne Medicines Ltd. trades under the ticker ONC on the Nasdaq.

What is BeOne Medicines Ltd.'s market cap?

BeOne Medicines Ltd. is a large cap stock with a market cap of about 40.3 billion dollars.

How does BeOne Medicines Ltd. make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves ONC stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow ONC stock every day?

Add ONC to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow ONC daily

A free brief on BeOne Medicines Ltd. and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • NVS · Novartis AG
  • AZN · Astrazeneca PLC
  • NVO · Novo Nordisk A S
  • VRTX · Vertex Pharmaceuticals Inc / Ma

Similar stocks

  • NVSNovartis AG
  • AZNAstrazeneca PLC
  • NVONovo Nordisk A S
  • VRTXVertex Pharmaceuticals Inc / Ma

Compare ONC: ONC vs NVS, ONC vs AZN, ONC vs NVO

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed